Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Compounding with Beta-1, 3-D-Glucan

Author(s):  Keller Ted

Issue:  Sep/Oct 2000 - Compounding for Immune System Disorders
View All Articles in Issue

Page(s):  342

Compounding with Beta-1, 3-D-Glucan Page 1

Download in electronic PDF format for $75

Abstract:  Beta-1,3-D-glucan, a homopolymer of glucose, is a brown powder consisting of beta-1,3-linked glucopyranose polymers, which are insoluble molecules in all solvents. In this article, various therapeutic applications of beta-1,3-D-glucan and its effect on the role of the macrophage in immune system functioning are presented. The author focuses on infectious diseases; allergy and breathing disorders; neoplastic disease and the side effects of treatment; diabetes, hypertension, cholesterol and liver disease; autoimmune disorders; dermatologic applications and additional benefits of treatment. She also provides four very brief case reports. She concludes that beta-1,3-D-glucan is a powerful adjunct to the treatment of several disorders and should be included in every compounding practice. Its disadvantage is that, if treatment fails, the expense of therapy has been wasted; however, therapeutic failures are infrequent.

Related Keywords: glucan, immune system, beta-1,3-D, homopolyer of glucose, infectious disease, allergy, breathing disorder, neoplastic disease, diabetes, hypertension, liver disease, autoimmune, dermatologic


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Compounding with Beta-1, 3-D-Glucan
Keller Ted
Sep/Oct 2000
Pg. 342

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

The Treatment of Canine Atopic Disease
Davidson Gigi S
May/Jun 2002
Pg. 210-215

Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
May/Jun 2003
Pg. 170-174

Treating Canine Hepatic Disease
Davidson Gigi S
May/Jun 2003
Pg. 188-191

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy
, Williams LaVonn
Jul/Aug 2022
Pg. 293-296

Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Davidson Michael G
Mar/Apr 2001
Pg. 92-94

Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R
, Fox Samantha, Mixon William, Vail Jane
Jan/Feb 2012
Pg. 34-41

Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs
Davidson Gigi S
Sep/Oct 2002
Pg. 332-336

Equine Cushing's Disease: A Clinical Update
Bliss George
Sep/Oct 2007
Pg. 384-388

Compounding for Treatment of Equine Infectious Diseases: An Overview
Bramwell Bethany L
Nov/Dec 2011
Pg. 450-457

Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Bramwell Bethany L
Mar/Apr 2010
Pg. 108-111

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2
Davidson Gigi S
Jul/Aug 2004
Pg. 277-283

Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1
Davidson Gigi S
May/Jun 2004
Pg. 169-172

Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease
Osburn Jennifer
May/Jun 2002
Pg. 171-176

Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Glasnapp Andrew
, Schaefer Erin
Jul/Aug 2000
Pg. 276-279

Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
Sep/Oct 2013
Pg. 380-383

Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Hagan John C III
, Everett Eric, Chamberlain Tyler
May/Jun 2020
Pg. 194-197

Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh
Vail Jane
Jan/Feb 2002
Pg. 16-18

Return to Top